VIZIENT, INC. for VIZIENT INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Hospital Group Purchasing Organizations - Advocated for the importance of hospital GPOs, and highlighted role in supporting supply chain resiliency to secure essential, authentic medical supplies for hospitals throughout the course of the COVID-19 pandemic. Advocated for greater transparency in the health care supply chain for drugs and medical devices and greater transparency into the decision-making of the Strategic National Stockpile. Supported passage of the Integrity, Notification, Fairness in Online Retail Marketplaces (INFORM) Consumers Act (S. 963). American Jobs Plan and American Families Plan Infrastructure Proposals - Monitored infrastructure proposals and advocated for support for investments in infrastructure for hospitals and health care providers, including physical structure improvements, workforce and graduate medical education support, efforts to prevent antimicrobial resistance and telehealth investments. Provider Relief Fund - Urged HHS and Congress to offer greater flexibility and extend deadlines for hospitals to utilize PRF funding and provide clear guidance on reporting expectations. Health Care Workforce - Urged passage of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708; S. 168). Drug Pricing - Monitored introductions of drug pricing legislation (H.R. 3, H.R. 19) and urged improvements to support hospital and patient access to needed medications. Unapproved Drugs Initiative - Engaged with HHS and the FDA to support modifications to the unapproved drugs initiative that would prevent or limit unintended price increases for older unapproved products. 340B Drug Pricing Program - Urged HHS to enforce guidance that would allow 340B Covered Entities to utilize contract pharmacies. Advocated for HHS to offer additional 340B Drug Pricing Program eligibility flexibility for hospitals that have had patient mix changed during the COVID-19 public health emergency. Stark Law and Anti-kickback Statute - Encouraged Congress to continue evaluating Stark and Anti-kickback statutes to better enable care coordination in value-based alternative payment models. Antimicrobial resistance (S. 2076) - Supported passage of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
Medicare/Medicaid MMM
American Jobs Plan and American Families Plan Infrastructure Proposals - Monitored release and negotiations around infrastructure proposals. Urged support for increasing available Medicare-supported Graduate Medical Education slots as part of infrastructure package. Raised opposition to using further extension of Medicare sequestration or repurposing unused provider relief funding as offsets for bipartisan infrastructure package. Health care Workforce - Supported legislation (S.834/H.R. 2256; S. 1438) to increase the number of Medicare-supported Graduate Medical Education (GME) slots and increase funding for Children's Hospital GME in FY2021. Biosimilar Medications - Advocated for expanded use of biosimilar medicines. Supported passage of the Bolstering Innovative Options to Save Immediately on Medicines (BioSim) Act (H.R. 2815). Medicare Alternative Payment Models - Urged CMS and the Medicare Innovation Center to release more information on the Medicare Shared Savings Program and Direct Contracting models. Telehealth - Advocated for Congress to extend or make permanent flexibilities related to distant site and geographic limitations, expanding the provider types and services available to be reimbursed by Medicare. Urged passage of the CONNECT for Health Act (S. 1512/H.R. 2903). Medicaid Supplemental Funding Reporting - Urged HHS and CMS to engage with stakeholders to implement Medicaid supplemental funding reporting.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.